Location History:
- Flushing, NY (US) (2010 - 2020)
- San Diego, CA (US) (2024)
Company Filing History:
2 out of 26 
2 out of 4,447 
1 out of 42 
Years Active: 2010-2024
Title: Juqun Shen: Innovator in Antibody Therapeutics
Introduction
Juqun Shen is a prominent inventor based in Flushing, NY (US), known for his significant contributions to the field of antibody therapeutics. With a total of five patents to his name, Shen has made remarkable strides in developing innovative treatments for various medical conditions.
Latest Patents
Among his latest patents is a groundbreaking invention related to bispecific antibodies targeting immune checkpoints. This invention focuses on bispecific antibodies that antagonize human PD-1 and agonize human CD137, which may be useful for treating solid and hematological tumors, both alone and in combination with chemotherapy and ionizing radiation. Another notable patent is the anti-canine platelet derived growth factor receptor alpha antibody, which pertains to antibodies that bind to canine platelet derived growth factor receptor alpha.
Career Highlights
Throughout his career, Juqun Shen has worked with esteemed companies such as ImClone LLC and Eli Lilly and Company. His work in these organizations has allowed him to contribute to the advancement of medical science and therapeutic development.
Collaborations
Shen has collaborated with notable professionals in his field, including Dale Lincoln Ludwig and Zhenping Zhu. These collaborations have further enriched his research and innovation efforts.
Conclusion
Juqun Shen's work in the field of antibody therapeutics exemplifies the impact of innovative thinking in medicine. His patents and collaborations highlight his commitment to advancing healthcare solutions.